5IVR | pdb_00005ivr

Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-[[2-[(3S)-3-[(4-aminophenyl)methylamino]-4-hydroxy-butyl]phenyl]carbamoyl]-2,2-diphenyl-ethyl]carbamate


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free: 
    0.207 (Depositor), 0.200 (DCC) 
  • R-Value Work: 
    0.193 (Depositor), 0.180 (DCC) 
  • R-Value Observed: 
    0.193 (Depositor) 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 

Created with Raphaël 2.3.0Worse 01 BetterLigand structure goodness of fit to experimental dataBest fitted 6EGClick on this verticalbar to view details

This is version 1.2 of the entry. See complete history


Literature

Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group.

Bungard, C.J.Williams, P.D.Ballard, J.E.Bennett, D.J.Beaulieu, C.Bahnck-Teets, C.Carroll, S.S.Chang, R.K.Dubost, D.C.Fay, J.F.Diamond, T.L.Greshock, T.J.Hao, L.Holloway, M.K.Felock, P.J.Gesell, J.J.Su, H.P.Manikowski, J.J.McKay, D.J.Miller, M.Min, X.Molinaro, C.Moradei, O.M.Nantermet, P.G.Nadeau, C.Sanchez, R.I.Satyanarayana, T.Shipe, W.D.Singh, S.K.Truong, V.L.Vijayasaradhi, S.Wiscount, C.M.Vacca, J.P.Crane, S.N.McCauley, J.A.

(2016) ACS Med Chem Lett 7: 702-707

  • DOI: https://doi.org/10.1021/acsmedchemlett.6b00135
  • Primary Citation of Related Structures:  
    5IVQ, 5IVR, 5IVS, 5IVT

  • PubMed Abstract: 

    A novel HIV protease inhibitor was designed using a morpholine core as the aspartate binding group. Analysis of the crystal structure of the initial lead bound to HIV protease enabled optimization of enzyme potency and antiviral activity. This afforded a series of potent orally bioavailable inhibitors of which MK-8718 was identified as a compound with a favorable overall profile.


  • Organizational Affiliation

    Merck Research Laboratories , 770 Sumneytown Pike, PO Box 4, West Point, Pennsylvania 19486, United States.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Protease
A, B
99Human immunodeficiency virus 1Mutation(s): 0 
Gene Names: pol
UniProt
Find proteins for Q77VV3 (Human immunodeficiency virus type 1)
Explore Q77VV3 
Go to UniProtKB:  Q77VV3
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ77VV3
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.50 Å
  • R-Value Free:  0.207 (Depositor), 0.200 (DCC) 
  • R-Value Work:  0.193 (Depositor), 0.180 (DCC) 
  • R-Value Observed: 0.193 (Depositor) 
Space Group: P 21 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 58.19α = 90
b = 85.96β = 90
c = 46.35γ = 90
Software Package:
Software NamePurpose
Aimlessdata scaling
BUSTERrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
BUSTERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 

Created with Raphaël 2.3.0Worse 01 BetterLigand structure goodness of fit to experimental dataBest fitted 6EGClick on this verticalbar to view details

Entry History 

Deposition Data

  • Released Date: 2016-05-18 
  • Deposition Author(s): Su, H.P.

Revision History  (Full details and data files)

  • Version 1.0: 2016-05-18
    Type: Initial release
  • Version 1.1: 2016-08-10
    Changes: Database references
  • Version 1.2: 2024-03-06
    Changes: Data collection, Database references, Derived calculations